Boca Raton, FL -- (SBWIRE) -- 09/20/2013 -- StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners. StockFreak focuses on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks – DryShips Inc.(NASDAQ:DRYS), Sarepta Therapeutics Inc(NASDAQ:SRPT ), Questcor Pharmaceuticals Inc(NASDAQ:QCOR), FreeSeas Inc.(NASDAQ:FREE)
DryShips Inc.(NASDAQ:DRYS) increased 0.06% at the price of $3.61recently on a traded volume of 6.23 million shares, in comparison to 15.20 million shares of average trading volume. So far this year, the stock is up over +129.75%.
The company has a total market capitalization of $1.46 billion and its total outstanding shares are 403.76 million. DryShips Inc. owns drybulk carriers and tankers that operate worldwide. The company, through its majority owned subsidiary, Ocean Rig, owns and operates 10 offshore ultra deepwater drilling units comprising 2 ultra deepwater semisubmersible drilling rigs and 8 ultra deepwater drillships, three of which are scheduled to be delivered to the company during 2013 and one of which is scheduled to be delivered during 2015.
For How Long DRYS will Fight for Profitability? Read This Trend Analysis report
Sarepta Therapeutics Inc(NASDAQ:SRPT ) declined -0.17% at the trading price of $36.63 on a traded volume of 3.08 million shares till now, whereas its average trading volume is 1.34 million shares. In the last three months, the stock is down -8.48%. The Intra-day range for the stock is $36.07 and $40.00. Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare and infectious diseases.
For How Long SRPT Gloss will Attract Investors? Find out via this report
Questcor Pharmaceuticals Inc(NASDAQ:QCOR) slipped down -7.38% at the $56.26 recently. So far in three months, the stock is up +23.11%. The 52-week range for the stock is $17.25 and $74.76. Its introductory price for the day was $61.50, with the overall traded volume of 1.36 million shares. Questcor Pharmaceuticals, Inc., a biopharmaceutical company, provides drugs for the treatment of multiple sclerosis, nephrotic syndrome, and infantile spasms indications. It primarily offers H.P.
Has QCOR Found The Bottom And Ready To Gain Momentum? Find Out Here
FreeSeas Inc.(NASDAQ:FREE) after opening its shares at the price of $0.51, added +9.04% , its recent trading price was $0.504 for the day. The stock moved on a traded volume of 5.99 million shares, in comparison to 6.43M shares of average trading volume.
The 52-week range for the stock is $0.17 and $5.80. Its introductory price for the day was $0.51. FreeSeas Inc., through its subsidiaries, provides drybulk shipping services. Its vessels carry various drybulk commodities, including iron ore, grain, and coal, as well as bauxite, phosphate, fertilizers, steel products, cement, sugar, and rice.
Will FREE Continue To Move Higher? Find Out Here
StockFreak scours the market on a daily basis looking for the hottest penny stocks that may be the next big runners. We strive to provide you with only the most opportunistic picks by pouring over mountains of data and charts. How often we send out our alerts is dependent on how often we find something worthwhile.
GENERAL NOTICE AND DISCLAIMER - PLEASE READ CAREFULLY THE FOLLOWING NOTICE AND DISCLAIMER MUST BE READ AND UNDERSTOOD AND YOU MUST AGREE TO THE TERMS CONTAINED THEREIN BEFORE USING THIS WEBSITE OR SUBSCRIBING TO OUR NEWSLETTER.
We are engaged in the business of advertising and promoting companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Neither the owner of StockFreak.com nor any of its members, officers, directors, contractors or employees are licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed on StockFreak.com. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. StockFreak.com makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website.
StockFreak.com has been retained by an unrelated third party to perform promotional and advertising services for a limited time with respect to the company we are profiling or discussing on this website and in exchange for such services has received cash compensation from such third party. Questions regarding this website may be sent to info@StockFreak.com.
Read Our Disclaimer at: http://www.stockfreak.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)